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Background: Recent advances in multi-slice computed tomography (MSCT) and 
three-dimensional computed tomography (3D CT) provide good-resolution images 
and short scan time for complete diagnosis of congenital heart disease (CHD). In the 
present study, we found that MSCT rapidly provides clinically relevant information 
for diagnosing extracardiac vascular anatomy in neonates with CHD. It is less invasive, 
necessitating only minimum or no sedation and a relatively small amount of contrast 
material. These advantages are crucial, especially for critically ill neonates.
Methods: Between January 2007 and December 2008, MSCT scans were conducted on 
41 neonates who were admitted to our neonatal intensive care unit. All the neonates 
were suspected to have complex CHD after an initial echocardiography examination. 
The scans were focused on detecting extracardiac vascular anatomy and abnormali-
ties. All the image data sets were sent to image processing workstations for multipla-
nar interactive viewing and 3D reconstruction.
Results: High-resolution MSCT scan images were obtained from 41 patients. Reported 
indications and findings of extracardiac abnormalities and related structural anat-
omy pertaining to congenital heart disease from MSCT and 3D CT findings were 
confirmed by clinical and surgical findings by a team of multidisciplinary congenital 
heart disease specialists.
Conclusion: Based on clinical and surgical confirmation of the MSCT scan results from a 
multidisciplinary congenital heart disease specialist team, we concluded that adequate 
information on CHD, specifically that regarding extracardiac abnormalities of the 
anatomy, can be obtained and MSCT can be used to replace cardiac catheterization.
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1.  Introduction
Precise investigation of the anatomy of congenital 
heart disease (CHD) is critical. Echocardiography is 
used as a non-invasive primary means of evaluating 
cardiac abnormalities that provides sufficient in-
formation about the intracardiac structure. How-
ever, it does not provide sufficient information on 
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extracardiac anatomy.1,2 Thus, cardiac catheteri-
zation often remains the gold standard for the 
complete diagnosis of CHD. However, cardiac cath-
eterization is an invasive procedure with recognized 
risks,3,4 especially in neonates with an unstable 
condition. Thus, there is the need for developing 
a non-invasive method to accurately assess the 
extracardiac morphology.
Recent advances in multi-slice computed tomog-
raphy (MSCT) and three-dimensional (3D CT) soft-
ware provide good resolution of images and short 
scan time. Studies are still limited concerning the 
diagnostic accuracy and clinical feasibility in re-
placing catheterization, especially to evaluate ex-
tracardiac vascular abnormalities in neonates.5−14 
There fore, the purpose of our study was to illustrate 
the clinical usefulness of MSCT and 3D CT in anatomi-
cal delineation of extracardiac vascular abnormal-
ities in neonates.
2. Materials and Methods
Between January 2007 and December 2008, we con-
ducted MSCT scans on 41 neonates who were ad-
mitted to our neonatal intensive care unit under the 
impression of complex CHD after routine echocar-
diography examination. Complex CHD was defined 
as CHD with more than two components of congen-
ital cardiac structural abnormalities.
The 41 neonates (referred to as “patient” from 
now on) included in this study consist of 20 males 
and 21 females with a median age of 15 days (range 
from less than 1 day to 30 days). Five patients were 
subjected to 16-slice acquisition, while 36 patients 
were imaged with 64-slice CT. Prior to the scan, pos-
sible adverse effects of contrast medium injection 
and radiation exposure were thoroughly explained 
to the patients’ parents, who gave informed signed 
consent. Oral chloral hydrate (50−100 mg/kg) or 
intravenous midazolam (0.05−1 mg/kg) were used 
as sedation. The patients were either free-breathing 
or intubated and mechanically ventilated.
2.1. Scanning techniques
The CT examinations were performed on a 16-MSCT 
scanner (Sensation 16; Siemens Medical Solutions, 
Munich, Germany) or a 64-MSCT scanner (Aquilion 64; 
Toshiba Medical Systems Co., Tokyo, Japan) using 
retrospective electrocardiogram (ECG) gating or non-
gating technique according to the clinical informa-
tion. The scanning parameters for the 16-MSCT and 
64-MSCT scanner were as follows: kVP, 80; mA, 90−
100; tube rotation, 0.42 and 0.35; detector collima-
tion 0.75 mm and 0.50 mm; reconstructed width, 
0.75 mm and 0.50 mm; reconstructed interval, 0.5 mm 
and 0.3 mm; pitch, 0.23; and field of view, 15−25 cm. 
The total volume of contrast agent used for cardio-
vascular CT angiography was determined on the basis 
of the body weight (2 mL/kg). Contrast agent con-
sisting of Iodixanol (Visipaque-320; GE Healthcare, 
Waukesha, WI, USA) or Iopamidol (Iopamidol-370; 
Bracco SpA, Milano, Italy) was injected at 0.06 mL/
kg/s. The saline flush was performed using 1 mL/kg 
of normal saline to minimize peri venous artifacts 
in the superior vena cava. To ensure optimal opaci-
fication of cardiac chambers, scanning was started 
by manual bolus tracking technique at left atrial 
level (CARE bolus; Siemens, or SureStart; Toshiba). 
ECG-gated image data sets of the entire thorax 
were further retrospectively reconstructed accord-
ing to the simultaneously recorded electrocardio-
gram for up to 10 different phases of the cardiac 
cycle at every 10% of the RR interval.
During the scan, particular attention was paid 
to the following extracardiac anatomy parameters: 
caliber of the proximal branch pulmonary arteries 
and their confluence; anomalous pulmonary connec-
tions; number and size of aortopulmonary collateral 
arteries; presence of patent ductus arteriosus; ca-
liber of the great artery and its connections; pres-
ence of the vascular rings and slings; and patency of 
surgical shunts and conduits. All were clearly veri-
fied through the 3D images.
Effective scan times were very short, with a 
single MSCT cardiac examination taking less than 
a minute to complete. No circulatory or respiratory 
collapse was noted during the procedure, even in 
patients with congestive heart failure or pulmonary 
congestion.
After image acquisition, the patients were sent 
back to the neonatal intensive care unit to con-
tinue cardiac intensive care while post-acquisition 
processing was made off-line for further evaluation 
of cardio-vascular anatomy. All the image data sets 
were sent to image processing workstations for mul-
tiplanar interactive viewing and 3D reconstruction, 
including a Leonado 3D workstation (Siemens Medical 
Solutions) and a Vitrea 2 (Vital Images, Minnetonka, 
MN, USA).
A multidisciplinary congenital heart disease team 
consisting of three pediatric cardiologists, one sur-
geon with expertise in congenital heart surgery, and 
two cardiac radiologists decided if further diagnos-
tic cardiac catheterization was necessary.
3. Results
Results of the MSCT scans on 41 patients are tabu-
lated in Table 1. Based on CT indication and report, 
the following diagnoses were obtained: 13 patients 
with pulmonary atresia (PA) or severe pulmonary 
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stenosis (PS) and tetralogy of Fallot (TOF; Figures 1 
and 2), 3 patients with pulmonary atresia and in-
tact ventricular septum (PA-IVS), 7 patients with 
PA or severe PS and other complex heart disease, 3 
patients with hypoplastic left heart syndrome 
(HLHS; Figure 3), 7 patients with coartaction of aorta 
(CoA), 3 patients with total anomalous pulmonary 
venous return (TAPVR; Figure 4), 2 patients with 
partial anomalous pulmonary venous return (PAPVR; 
Figure 5), 1 patient with large patent ductus arte-
riosus (PDA) alone and 2 patients with vascular 
slings.
As a result of the findings (see Table 1) and diag-
noses on the 41 patients, 35 patients received pal-
liative shunt procedures or complete repair surgery. 
Four patients underwent evaluation for vascular 
ring. Two patients showed no evidence of Blalock-
Taussig shunt occlusion (Figure 6). Findings at surgery 
confirmed the 3D image results obtained based on 
CT indication and report. The multidisciplinary con-
genital heart disease team made the final clinical 
consensus diagnosis, integrating the surgical, echo-
cardiographic and CT findings with clinical course. 
In addition to evaluation of the native vascular 
structures, a partly thrombolized Blalock-Taussig 
shunt was clearly seen in one patient (Patient 8); 
echocardiography did not show the thrombosis. 
Pneumonia (Patient 30), lung atelectasis (Patient 
21), pulmonary edema (Patients 18 and 22) and 
pneumothorax (Patient 34) were also defined by 
Figure 1 Tetralogy of Fallot with pulmonary atresia 
(PA) in an 11-day-old neonate (patient 4). PA with invisi-
ble main pulmonary artery trunk. Bilateral superior vena 
cava (SVC) and patent ductus arteriosus (PDA) are also 
clearly seen.
Figure 2 Tetralogy of Fallot with pulmonary atresia in 
a 5-day-old neonate (patient 2). Multiple aortopulmo-
nary collateral arteries (MAPCA) arise from the descend-
ing aorta (DAo).
Figure 3 Hypoplastic left heart syndrome variant and subaortic stenosis in a 28-day-old infant (patient 37). (A) 
Hypolastic ascending aorta (AAo) compared to pulmarny artery (Pa). (B) Small left ventricle (LV) with subaortic steno-
sis (arrow) and large relatively hypertrophy right ventricle (RV).
A B
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the images. Bronchogenic cysts were also found in 
one patient (Patient 18). A patient with sinus veno-
sus atrial septal defect was misdiagnosed in MSCT 
as ostium secundum atrial septal defect (Patient 
28). Forty MSCT indications and reports were con-
firmed by our multidisciplinary congenital heart 
disease team through clinical and surgical find-
ings. This established an overall 98% accuracy of 
MSCT for delineating cardiac abnormalities.
4. Discussion
Complex CHD tends to fall into three categories: 
extracardiac abnormalities, cardiac abnormalities, 
and connection problems. Echocardiography with 
color and spectral Doppler sonography is a dynamic 
study which can also provide anatomic information 
with a focus on intracardiac lesions. Echocardiog-
raphy has its limitations with regards to imaging 
extracadiac anatomy. These include the pulmonary 
veins, branch pulmonary arteries, peripheral (Black-
Taussig) shunts, vascular rings and aortopulmonary 
collateral arteries. In addition, ultrasound cannot 
penetrate anatomic structures obscured by the 
bony chest wall, surgical dressings and gas within 
the surrounding lung. Traditionally, cardiac cathe-
terization was the gold standard for anatomical 
delineation and complete diagnosis of CHD how-
ever, its invasive nature with associated morbidity 
and mortality such as cardiac arrhythmia, vessel 
damage, bleeding, infection, stroke, prolonged radi-
ation dose exposure and reaction to contrast admin-
istration cannot be ignored. The risk of subjecting 
predisposed neonates and infants to high-risk pro-
cedures has important implications in the selection 
of the type of imaging modality.
MSCT data acquisition and manipulation in a 
non-invasive environment can be extended to an 
advanced 3D image-rendering process which is ca-
pable of providing high-resolution images of soft 
tissue structures of the extracardiac vascular anat-
omy in CHD. Images obtained using this technique 
can provide morphology and size of the pulmonary 
annulus and bilateral pulmonary arteries.7 Pulmo-
nary arterial diameter and quantification of steno-
sis by MSCT correlate well with the findings in 
surgery and continue to play an ongoing role in its 
contribution to corrective surgery such as Fontan 
operation, radical surgery for tetralogy of Fallot, 
Rastell and Norwood operation.15,16 This type of as-
sessment is critical with these patients as poor out-
comes and even early death have been reported to 
associate with hypoplastic or distorted pulmonary 
arteries.17,18
MSCT is good at demonstrating the vascular ring 
and slings, and has the ability to demonstrate anom-
alous anatomical relationships between vascular and 
tracheal structures. Effective use of window width 
and level setting is a non-invasive technique of pro-
ducing relief of the tracheal bronchial tree in the 
coronal plane to determine a potential narrowing.19 
This same technique is also useful in assessing the 
Blalock-Taussig shunt. The patency of vascular shunts 
are well visualized, while thrombosis that do not 
show in echocardiography can be identified clearly. 
Arch obstruction and abnormal pulmonary venous 
connections in neonates usually require surgery and 
Figure 4 Heterotaxy syndrome, complex heart with 
supracardiac total anomalous pulmonary venous return 
in a 5-day-old infant (patient 26). The four pulmonary 
veins converge into a common pulmonary vein (PV) and 
then drain into the right superior vena cava via a vertical 
vein (VV).
Figure 5 Atrial septal defect with partial anomalous 
pulmonary venous return in a 28-day-old infant (patient 
29). Right pulmonary vein trunk (RPV) and left inferior 
pulmonary vein (LIPV) converge to the coronary sinus 
(CS) and drain into the right atrium. Left superior pul-
monary vein (LSPV) drainage into the left atrium.
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preclude an invasive cardiac catheterization pro-
cedure. In this instance, MSCT as an adjunct to 
echocardiography can be considered as the pre-
ferred alternative to cardiac catheterization, espe-
cially in the event that echo cardiography is unable 
to provide the supportive preoperative informa-
tion. Moreover, eliminating potential problems such 
as pneumonia, atelectasis, bronchogenic cysts, pul-
monary embolism, pneumothorax and pulmonary 
edema, is an added bonus.10
Magnetic resonance imaging (MRI) and magnetic 
resonance angiography can also provide 3D images 
of extracardiac structures, and even features supe-
rior to CT.20−26 MRI, without the hazard of ionizing 
radiation exposure, has excellent soft-tissue contrast 
and provides superior visualization of intracardiac 
abnormalities. It allows accurate quantification of 
volumes and mass of cardiac chambers, regurgita-
tion volumes, and regional ventricular function.27 
However, MRI requires long scan time and effective 
sedation during noisy scanning. Mechanical ventila-
tion, electrocardiographic monitoring equipment, 
or infusion pumps are often incompatible with the 
strong magnetic field. Furthermore, MRI cannot be 
used in most postoperative patients with pacemak-
ers, vascular grafts, surgical clips, and stents that 
would lead to artifacts obscuring anatomic detail. 
The application of MRI to the critically ill patient is 
therefore impractical. MSCT, on the other hand, is 
fast and efficient, with very short scan times, and 
is not associated with the presence of strong mag-
netic fields.
Our study has several limitations. The sample 
size was small; follow-up studies using larger sample 
sizes will enable generalized correlations between 
MSCT scans and extracardiac vascular abnormalities 
in neonates with CHD. As none of our patients un-
derwent invasive cardiac catheterization proce-
dures, we did not have a control group for comparison 
purposes in this study. Hemodynamic, functional and 
physiologic data (intracardiac and intravascular pres-
sure curves, oxygen saturation data) were not ob-
tained in our study. The effective radiation exposure 
dose associated with MSCT was not calculated in 
our examination. The issue of radiation exposure is 
extremely important in children since they are more 
radiosensitive than adults. A potential for the de-
velopment of radiation-induced malignancies still 
is a concern, but it is difficult for us to estimate 
the effective dose for patients who will undergo 
complex procedures.28
In one of our cases where MSCT was used, there 
was a misdiagnosis of an ostium secundum atrial 
septal defect over a sinus venosus atrial septal de-
fect. As this abnormality was of the intracardiac 
type, echocardiography is considered to be the more 
appropriate choice of study.
In summary, echocardiography and MSCT should 
be used adjunctively in providing surgeons with 
valuable pre-surgical information. This in effect 
could preclude the patient from having to undergo 
diagnostic cardiac catherterization procedures.
5.  Conclusion
MSCT and 3D CT provide high speed (short scan-
ning time), high resolution and contrast images, 
which contributes to the increased reliability and 
success rate of CHD diagnosis. Such qualities of this 
non-invasive technique allow MSCT to provide in-
formation for the accurate diagnosis of CHD with 
extracardiac structural abnormalities.
With state-of-the-art MSCT, accurate information 
for surgical or other procedures could be acquired 
from those neonates clinically assessed to have ex-
tracardiac abnormalities as one of the components 
of their CHD. Diagnostic catheterization was deemed 
to be a less suitable choice for these patients. We 
conclude that MSCT provides sufficient diagnostic 
information on neonates and infants with extracar-
diac abnormalities.
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